A decision system for early development
How a medicines question earns the right to advance.
You should be able to see what is known, what remains uncertain, who has authority, and what evidence would change the next decision.
- 01Need
- 02Evidence
- 03Test
- 04Decision
Method | Evidence first
Authority | Human
Outcome | Advance, redesign, pause or stop
The evidence ledger
Six states. One honest record.
A status changes only when the supporting evidence, authority and review record change. Interest alone does not move the work.
- 01
State 01
Open question
The need, hypothesis and uncertainty are defined. - 02
State 02
Source reviewed
Relevant evidence, limitations and contrary findings are recorded. - 03
State 03
Rights clarified
Access, ownership and permitted use are documented. - 04
State 04
Work authorised
Scope, owner, resources and safety responsibilities are approved. - 05
State 05
Result reviewed
The result and remaining uncertainty are assessed by accountable people. - 06
State 06
Decision recorded
Advance, redesign, pause or stop is documented with a reason.
01
Before work begins
Four tests make the next decision useful.
The aim is not to remove uncertainty. It is to identify the uncertainty that matters and choose work capable of reducing it.
Relevance
What human, scientific or system need is important enough to examine?
Evidence
What supports the question, what challenges it and what remains uncertain?
Control
Can the relevant rights, data and responsibilities be documented?
Decisive work
What result would genuinely change the next decision?
Future operations
The system has to survive the factory floor.
A development model becomes useful when evidence, quality, manufacturing reality and named human authority remain connected. Automation can strengthen that chain. It cannot replace it.
No operating line, GMP status, production capacity or deployed robotics is claimed.Decision discipline
Stopping can be the right result.
Good development work does not force every idea forward. A documented stop protects time, resources and trust. It also records what was learned, so the same weak assumption is not recycled later.
Human authority
Technology can organise the record. It cannot own the judgement.
Technology may organise sources, uncertainty and review records. It cannot inherit scientific judgement, safety responsibility or the authority to expose people to risk.
Accountable people define the question, approve the work, examine the result and record the decision. The system should make that responsibility clearer, not hide it.
Distinct by design
Medicines intelligence does not automatically create a development programme.
PHARMORIS is NEUVIOR’s current product priority. VARUNÉ Labs is a separate predevelopment concept. No automatic pathway, shared data flow, customer transfer or programme selection is claimed.
Any future exchange would require an explicit purpose, lawful rights, governance and authorised review. The founder thesis can connect questions without merging responsibilities.
See the public relationship mapQuestions and answers
Make the evidence state visible.
Why begin with an open question?
An open question keeps the need, evidence gap and uncertainty visible. It prevents an early idea from being described as a finished programme.
Why must rights be clarified?
Scientific interest does not create ownership or permission. Relevant access, ownership and permitted use should be documented before work is represented as controlled.
Can a decision be to stop?
Yes. A documented stop can protect people, time, resources and trust when evidence does not support progress.
Can technology make the scientific decision?
No. Technology may organise sources, uncertainty and review records. Accountable people retain scientific judgement, safety responsibility and decision authority.
Does this model create a pathway from PHARMORIS to VARUNÉ Labs?
No automatic pathway is claimed. PHARMORIS and VARUNÉ Labs have distinct scopes under NEUVIOR. Any exchange requires an explicit purpose, lawful rights, governance and authorised review.
Return to the thesis